Gene therapies target Amish and Mennonite children — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- One doctor in Pennsylvania Dutch country has long collaborated with biotech companies and academics to develop gene therapies.
- The gene therapies are aimed at the sickest children in local Amish and Mennonite communities as part of an effort framed as one of biotech’s most vexing problems.
Why it matters: For the sickest children in Pennsylvania Dutch country’s Amish and Mennonite communities, the collaboration creates a direct gene-therapy development path through one doctor’s work with biotech companies and academics. It channels the partners’ work toward one defined pediatric population, giving companies and academics a shared local target for the therapies under development.
Ask SkimNews
